Figure 3.
Change in MBQ score between measurement at the end of follow-up and at baseline. Higher scores indicate worse QoL. Mean difference with corresponding 95% CI: ∗AUB (n = 50) vs no AUB (n = 24): 5.9 (−0.1 to 11.8). ∗∗New-onset AUB (n = 30) vs no AUB (n = 24): 9.2 (3.4-15.0). ∗∗∗New-onset AUB (n = 30) vs AUB with PBAC >100 at baseline (n = 16): 9.3 (0.9-17.7).

Change in MBQ score between measurement at the end of follow-up and at baseline. Higher scores indicate worse QoL. Mean difference with corresponding 95% CI: ∗AUB (n = 50) vs no AUB (n = 24): 5.9 (−0.1 to 11.8). ∗∗New-onset AUB (n = 30) vs no AUB (n = 24): 9.2 (3.4-15.0). ∗∗∗New-onset AUB (n = 30) vs AUB with PBAC >100 at baseline (n = 16): 9.3 (0.9-17.7).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal